IBDEI0SS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13936,2)
 ;;=^7648
 ;;^UTILITY(U,$J,358.3,13937,0)
 ;;=715.37^^74^849^29
 ;;^UTILITY(U,$J,358.3,13937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13937,1,3,0)
 ;;=3^715.37
 ;;^UTILITY(U,$J,358.3,13937,1,5,0)
 ;;=5^Arthritis, Osteoarthrosis- ankle /foot/toe 
 ;;^UTILITY(U,$J,358.3,13937,2)
 ;;=^272156
 ;;^UTILITY(U,$J,358.3,13938,0)
 ;;=714.0^^74^849^32
 ;;^UTILITY(U,$J,358.3,13938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13938,1,3,0)
 ;;=3^714.0
 ;;^UTILITY(U,$J,358.3,13938,1,5,0)
 ;;=5^Arthritis, Rheumatoid
 ;;^UTILITY(U,$J,358.3,13938,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,13939,0)
 ;;=711.07^^74^849^31
 ;;^UTILITY(U,$J,358.3,13939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13939,1,3,0)
 ;;=3^711.07
 ;;^UTILITY(U,$J,358.3,13939,1,5,0)
 ;;=5^Arthritis, Pyogenic/Septic- ankle & foot
 ;;^UTILITY(U,$J,358.3,13939,2)
 ;;=^271953
 ;;^UTILITY(U,$J,358.3,13940,0)
 ;;=716.17^^74^849^33
 ;;^UTILITY(U,$J,358.3,13940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13940,1,3,0)
 ;;=3^716.17
 ;;^UTILITY(U,$J,358.3,13940,1,5,0)
 ;;=5^Arthritis, Traumatic arthropathy- ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,13940,2)
 ;;=^272186
 ;;^UTILITY(U,$J,358.3,13941,0)
 ;;=715.90^^74^849^30
 ;;^UTILITY(U,$J,358.3,13941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13941,1,3,0)
 ;;=3^715.90
 ;;^UTILITY(U,$J,358.3,13941,1,5,0)
 ;;=5^Arthritis, Osteoarthrosis- unspecified site-
 ;;^UTILITY(U,$J,358.3,13941,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,13942,0)
 ;;=V45.4^^74^849^34
 ;;^UTILITY(U,$J,358.3,13942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13942,1,3,0)
 ;;=3^V45.4
 ;;^UTILITY(U,$J,358.3,13942,1,5,0)
 ;;=5^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,13942,2)
 ;;=^97131
 ;;^UTILITY(U,$J,358.3,13943,0)
 ;;=440.20^^74^849^26
 ;;^UTILITY(U,$J,358.3,13943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13943,1,3,0)
 ;;=3^440.20
 ;;^UTILITY(U,$J,358.3,13943,1,5,0)
 ;;=5^Arterisclerosis obliterans- extermity
 ;;^UTILITY(U,$J,358.3,13943,2)
 ;;=^294064
 ;;^UTILITY(U,$J,358.3,13944,0)
 ;;=701.8^^74^849^35
 ;;^UTILITY(U,$J,358.3,13944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13944,1,3,0)
 ;;=3^701.8
 ;;^UTILITY(U,$J,358.3,13944,1,5,0)
 ;;=5^Atrophy, fat pad
 ;;^UTILITY(U,$J,358.3,13944,2)
 ;;=^88076
 ;;^UTILITY(U,$J,358.3,13945,0)
 ;;=V54.89^^74^849^15
 ;;^UTILITY(U,$J,358.3,13945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13945,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,13945,1,5,0)
 ;;=5^Aftercare,Post-op, Ortho
 ;;^UTILITY(U,$J,358.3,13945,2)
 ;;=Aftercare post Surg^328685
 ;;^UTILITY(U,$J,358.3,13946,0)
 ;;=V58.49^^74^849^16
 ;;^UTILITY(U,$J,358.3,13946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13946,1,3,0)
 ;;=3^V58.49
 ;;^UTILITY(U,$J,358.3,13946,1,5,0)
 ;;=5^Aftercare,following Surgery
 ;;^UTILITY(U,$J,358.3,13946,2)
 ;;=^295530
 ;;^UTILITY(U,$J,358.3,13947,0)
 ;;=274.00^^74^849^27
 ;;^UTILITY(U,$J,358.3,13947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13947,1,3,0)
 ;;=3^274.00
 ;;^UTILITY(U,$J,358.3,13947,1,5,0)
 ;;=5^Arthritis, Gouty NOS
 ;;^UTILITY(U,$J,358.3,13947,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,13948,0)
 ;;=736.76^^74^849^11
 ;;^UTILITY(U,$J,358.3,13948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13948,1,3,0)
 ;;=3^736.76
 ;;^UTILITY(U,$J,358.3,13948,1,5,0)
 ;;=5^Adductovarus (metatarsus) acquired
 ;;^UTILITY(U,$J,358.3,13948,2)
 ;;=^272748
 ;;^UTILITY(U,$J,358.3,13949,0)
 ;;=274.01^^74^849^28
 ;;^UTILITY(U,$J,358.3,13949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13949,1,3,0)
 ;;=3^274.01
 ;;^UTILITY(U,$J,358.3,13949,1,5,0)
 ;;=5^Arthritis, Gouty, Acute
 ;;^UTILITY(U,$J,358.3,13949,2)
 ;;=^338226
 ;;
 ;;$END ROU IBDEI0SS
